Latest filing published 02 Mar 2023 for Abbott Laboratories, €125k.
Gregory A. Ahlberg filed 14 disclosures at Abbott Laboratories, under the title SENIOR VICE PRESIDENT, between October 5, 2020 and March 2, 2023. Most of them date from 2021, with 8 filings.
On November 15, 2021, two sales are reported on the same day: EUR 2,450,556 and EUR 443,686. A sale of March 1, 2021 adds EUR 104,951. The 3 sales amount to EUR 3.0 million in total. No purchase is recorded. The rest of the record holds 9 share grants and 2 option exercises.
No filing falls in the last twelve months. They are published a median of 3 days after the trade, across 14 dated filings. The record ends in 2023, two years after the main sales.
Ahlberg's own market trades within 30 days of colleagues at Abbott Laboratories number 3, 3 and 2. All in the same direction. In the same order, the colleagues are Andrea F. Wainer, Daniel Gesua Sive Salvadori and Andrew H. Lane.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations